CELESTICA INC CLS
NYSE · XNYS · stock · Printed Circuit Boards
Chart by TradingView
6/9
Piotroski F — financial health
3.2
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $12.4B | $832.5M | $1.5B | — | $2.2B |
| 2024 | $9.6B | $428.0M | $1.0B | — | $1.9B |
| 2023 | $8.0B | $244.4M | $754.1M | — | $1.8B |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.2 (safe)
- Working capital / assets 0.24
- Retained earnings / assets 0.057
- EBIT / assets 0.144
- Equity / liabilities 0.444
Source: SEC EDGAR filings · CIK 0001030894 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.